The stock is in a recovery phase after a sharp downtrend, with a 1-year price change of -8.79% but a strong rebound from its 52-week low of $33.03. Currently at $49.42, it sits at 48.5% of its 52-week range ($33.03–$65.88), indicating it has recovered from the lows but remains well below the highs. This positioning suggests the stock is in a rebuilding phase, with potential for further upside if momentum continues, but still far from confirming a full trend reversal. Short-term momentum is robust, with a 1-month change of +18.57% and a 3-month change of +25.11%, significantly outperforming the S&P 500's 1-month return of 4.07% and 3-month return of 11.11%. This acceleration contrasts with the negative 1-year trend, signaling a potential trend reversal or mean reversion, supported by a relative strength of +14.5% over 1 month versus the S&P. The stock's beta of 1.279 indicates 27.9% more volatility than the market, amplifying both upside and downside moves. Key support is near the 52-week low of $33.03, while resistance is at the 52-week high of $65.88. A breakout above $65.88 would signal a strong uptrend resumption, while a breakdown below $33.03 could indicate renewed selling pressure. The stock's higher beta means it is more sensitive to market swings, requiring careful risk management.

Revenue has grown modestly, with Q4 2025 revenue of $3.632 billion, up 2.77% year-over-year from $3.534 billion in Q4 2024. However, the multi-quarter trend shows deceleration: Q3 2025 revenue was $3.766 billion (up 22.6% YoY from $3.072 billion), Q2 2025 revenue was $3.704 billion (up 27.9% YoY from $2.897 billion), and Q1 2025 revenue was $3.137 billion (up 40.5% YoY from $2.232 billion). The growth rate has slowed sharply from over 40% to under 3%, indicating a normalization post-pandemic and potential headwinds from fuel costs and demand. The Alaska Airlines segment contributed $3.828 billion, Hawaiian Airlines $1.381 billion, and Regional $0.83 billion, with Hawaiian providing diversification but also integration risks. Profitability is thin but positive: net income in Q4 2025 was $21 million, down from $71 million in Q4 2024, with EPS of $0.18 versus $0.56. Gross margin was 94.27% in Q4 2025, but this is inflated due to accounting treatment (cost of revenue only $208 million); operating margin was a slim 2.06%, and net margin was 0.58%. The company swung to a net loss of $166 million in Q1 2025, but recovered to profitability in subsequent quarters, though margins remain compressed compared to the 7.6% net margin in Q3 2024. The balance sheet shows elevated leverage: debt-to-equity of 1.67 and a current ratio of 0.50, indicating liquidity risk. Free cash flow was negative $339 million TTM, with Q4 2025 FCF of -$440 million due to heavy capital expenditures of $625 million. ROE is low at 2.43%, and the company does not pay a dividend, relying on external financing for growth.